Professional Documents
Culture Documents
Neurologic Disorder Handout
Neurologic Disorder Handout
PATHOPHYSIOLOGY
ASSESSMENT FINDINGS
INTERVENTIONS
MEDICATIONS
ENCEPHALITIS
- a severe inflammation of the brain
- an acute inflammatory process of the
brain tissue. HSV is the most common
cause of acute encephalitis
HERPES SIMPLEX VIRUS
ENCEPHALITIS
ARTHROPOD-BORNE VIRUS
ENCEPHALITIS
Arthoropod vectors transmit
several types of viruses that cause
encephalitis.
ISTIONKO/USTCON/05
Neuroimaging studies:
EEG : demonstrates a specific
wave pattern
CSF examination : reveals a high
opening pressure and low
glucose and high protein
levels
MRI : dx choice
PCR : identify the DNA bands of
the HSV specifically
Pharmacologic Management
Acyclovir
Nursing Management
Assessment of neurologic
function key to monitor
progression of disease
Comfort measures reduce
headache
Nursing care addressing
patient and family anxiety
Medical Management
No specific medication for
arboviral encephalitis
Nursing Management
Assessment of neurologic
status
Injury prevention
Public education
Mosquito control
None
FUNGAL ENCEPHALITIS
CREUTZFELDT-JAKOB DISEASE
& NEW-VARIANT CREUTZFELDTJAKOB DISEASE
- disease belong to a group of degenerative,
infectious neurologic disorders called
transmissible spongiform encephalopathies
ISTIONKO/USTCON/05
Medical Management
Directed at the causative fungus
and the neurologic consequences
of infection
Nursing Management
Early identification
Providing patients comfort
Monitoring serum creatinine and
blood urea nitrogen levels:
development of renal insufficiency
Providing support
Anti-seizure
Ampothericin B : treat fungi,
standard antifungal agent
Fluconazole (Diflucan) or
Flucytosine (5-FC, 5fluorocytosine, Ancobon) may be
administered in conjunction with
Ampothericin B
Diphenhydramine (Benadryl) and
acetaminophen (Tylenol) : to
prevent Amphotericin B side-effects
none
Medical Management
No effective treatment of CJD
or nvCJD
Nursing Management
Supportive and palliative care
Psychosocial and emotional
support of patients and families
throughout the course of the
illness is needed
Prevention of transmission
Aseptic technique
NEUROLOGIC DISORDER
PATHOPHYSIOLOGY
ASSESSMENT FINDINGS
INTERVENTIONS
MEDICATIONS
Assessment
Impaired neural function LOC
changes
Slowing of speech & delay in
response to verbal suggestions
Abnormal respiratory & vasomotor
response
Restlessness, confusion, increasing
drowsiness
Comatose, dilated & fixed pupils,
impaired respirations, death
Cerebral angiography, CT, MRI,
PET, transcranial doppler
Management
Monitor ICP through
ventriculostomy, subarachnoid bolt,
epidural monitor, fiberoptic monitor
Decrease cerebral edema using
osmotic diuretics
Corticosteroids for patients with
brain tumors
Fluid restriction
Maintain cerebral perfusion by fluid
volume & inotropic agents
CSF drainage
Hyperventilation for patients whose
ICP is unresponsive to conventional
therapies
Control fever by administering
antipyretic & muscle relaxants.
Prevent shivering.
Reduce metabolic demands using
high doses of barbiturates for
patients who are unresponsive to
conventional treatments
Measure venous oxygen saturation
in jugular bulb (SjO2)
Nursing interventions:
o Suction to maintain airway
o Avoid coughing, straining
o Auscultate lung fields q8h
o Elevate HOB 30 to 60 degrees
o Keep head in a neutral (midline)
position, with cervical collar to
promote venous drainage
NEUROLOGIC DYSFUNCTION
INCREASED INTRACRANIAL
PRESSURE
ISTIONKO/USTCON/05
o Prevent infection
SEIZURES
EPILEPSIES
Loss of consciousness
Excessive movement
Loss of muscle tone or movement
Disturbance of behavior, moos,
sensation & perception
Staring episode
Prolonged convulsive movement
with loss of consciousness
Simple partial: shaking of hand &
finger, jerking of mouth, talk
unintelligibly, dizziness, unusual &
unpleasant sights, sounds, odors,
tastes
Complex: motionless or moves
automatically, excessive emotions of
fear, anger, elation, irritability,
doesnt remember episode
Generalized: intense rigidity of
entire body followed by alternating
muscle relaxation & contraction,
simultaneous contractions of the
diaphragm & chest muscles
produces epileptic cry, tongue is
chewed, urinary & bowel
ISTIONKO/USTCON/05
During a seizure
Keep airway patent
o Observe & record the sequence
of symptoms
o Prevent injury & support patient
physically & psychologically
o Do not restrain
o Loosen clothing
After a seizure
o Document events leading to &
occurring during the seizure & to
prevent complications (eg,
aspiration & injury)
o Side lying position
o Suction
o Bed is placed in a low position
with side rails up & padded
IV Diazepam
Dilantin
Phenobarbital
Tegretol
STATUS EPILEPTICUS
incontinence
ECG & SPECT
Clinical or electrical seizures lasting
at least 30 minutes
IV diazepam, lorazepam or
fosphenytoin
CEREBROVASCULAR
DISORDERS
ISCHEMIC STROKE
ISTIONKO/USTCON/05
Motor loss
Because of a lesion of the upper
motor neurons
Hemiplegia paralysis of one side
of the body due to a lesion of the
opposite side of the brain
Hemiparesis weakness of one
side of the body
Early stage of stroke: flaccid
paralysis, loss or decrease in the
ACUTE PHASE:
Maintain patent airway
Maintain BP at 150/100 for cerebral
perfusion
Suction as Rx but not nasally for no
longer than 10 seconds
Monitor for increased ICP during
first 72 hrs.
ISTIONKO/USTCON/05
psychologoical effects
frontal lobe damage: impaired
learning capacity, memory,
intellectual fxns.
Limited attention span,
difficulties in comprehension,
forgetfulness, lack of
motivation, depression,
emotional lability, hostility,
frustration, resentment, lack of
cooperation.
ISTIONKO/USTCON/05
Intracerebral hemorrhage
HEMORRHAGIC STROKE
ISTIONKO/USTCON/05
Manifestations:
neurologic deficits
rupture of AVM: sudden,
severe headache, loss of
consciousness, pain and
rigidity of the back of the neck
(nuchal rigidity) and spine due
to meningeal irritation, tinnitus,
dizziness, hemiparesis, severe
bleeding
MEDICAL
To allow the brain to recover from the
initial insult, to minimize the risk for
rebleeding, top prevent or treat
complications
Bedrest with sedation to prevent
agitation and stress, mgt of vasospasm,
analgesics for pain, elastic compression
stockings to prevent deep vein
thrombosis.
Complications and mgt:
Cerebral hypoxia and
decreased blood flow
adequate hydration to reduce
blood viscosity and improve
cerebral blood flow; avoid
extremes of HPN or
hypotension to prevent
changes in cerebral blood flow
and potential bleeding; admin
of 02 as ordered
Vasospasm- narrowing of the
lumen; clipping of aneurysm;
removal of blood from the
basal cisterns around the
major arteries; IV admin of
Nimodipine (ca channel
blocker) or fluid volume
expanders to prevent ischemic
deterioration
Increased ICP CSF drainage
rupture
- most common in young people
subarachnoid hemorrhage
- as a result of an AVM, intracranial
aneurysm, trauma or HPN
- most common cause: leaking
aneurysm in the area of the
Circle of Willis or a congenital
AVM of the brain
SURGICAL MGT
Ligation or clipping of
aneurysm to exclude
aneurysm from cerebral
circulation
Extracranial-intracranial
bypass to establish collateral
blood supply to allow surgery
on the aneurysm
Endovascular tx occlusion of
the parent artery
Aneurysm coiling obstruction
of the aneurysm site with a coil
Postop complications:
disorientation, amnesia,
Korsakoffs syndrome,
personality changes,
injtraoperative embolism,
internal artery occlusion FE
imbalance, GI bleeding
NURSING
ISTIONKO/USTCON/05
ISTIONKO/USTCON/05
INFECTIOUS
MENINGITIS- inflammation of the
meninges, the protective membrane lining the
brain and spinal cord.
ISTIONKO/USTCON/05
Initial Manifestations:
- headache
- fever
Classical Manifestations:
- nuchal rigidity
- (+) Kernigs sign
- (+) Brudzinskis sign
- photophobia
Others:
- rash; skin lesions (ranging from
petechial rash with purpuric lesions
to large areas of ecchymosis)
- disorientation and memory
impairment
- behavioral manifestations
- lethargy, unresponsiveness and
coma may develop as the illness
progresses
- seizures (sec. to focal areas of
cortical irritability )
- Increased ICP (sec. to
Prevention: vaccination
Nursing. Mgt.:
- Neurologic status and VS
continually assessed
- Monitoring of body wt. serum
electrolytes and urine volume,
specific gravity and osmolality
- Protect client from injury (seizure
or altered LOC)
- Preventing complications
- Instituting droplet precaution until
24 hrs. after the initiation
Early administration of antibiotic
( penicillin e.g. ampicillin and piperacillin;
cephalosporin e.g. ceftriaxone
sodium and cefotaxime sodium,)
( Vancomycin HCL)
accumulation of purulent
exudates); as manifested by
decrease LOC and focal motor
deficits)
- Fulminating infection
BRAIN ABSCESS
is a collection of either encapsulated or free
pus within brain tissue arising from a primary
focus elsewhere(e.g. ear, mastoid sinuses,
nasal sinuses, heart, distal bones, lungs, or
primary bacteremia) or is a collection of
infectious material within the tissue of the
brain.
- relatively rare but it is a
complication encountered
increasingly in patients whose
immune system have been
suppressed
- The frontal lobe is the most
Diagnostic evaluation:
- CBC with differential
( Increased WBC especially
polymorphonuclear leukocytes)
- Blood culture (to indicate the
organism)
- Lumbar puncture with CSF
examination
(moderately elevated CSF pressure
leukocytes; decrease glucose level;
increase protein level; (+) gram
stain)
Med. Mgt.:
- Antimicrobial therapy
- Surgical incision or aspiration
(CT-guided needle aspiration
under local anesthesia)
- Penicillin G and
chloramphenicol
- Corticosteroids
- Antiseizure meds
Adjunctive therapy
(Dexamethasone)
Dehydration and shock are treated
with fluid volume expanders.
Seizures are controlled with
phenytoin (Dilantin)
ISTIONKO/USTCON/05
ISTIONKO/USTCON/05
present
Frontal Lobe
- Hemiparesis
- Aphasia (expressive)
- Seizures
- Frontal headache
Temporal Lobe
- Localized headache
- Changes in vision
- Facial weakness
- Aphasia
Cerebellar Abscess
- Occipital headache
- Ataxia (inability to coordinate
movements)
- Nystagmus (rhythmic, involuntary
movements of the eye)
Diagnostic Evaluation:
- Repeated neurologic examinations
- MRI
Nsg. Mgt.:
- Ongoing assessment of
12eurologic status
- Administering meds
- Assessing the response to
treatment
- Providing supportive care
Antimicrobial therapy
NEUROLOGIC DISORDER
AUTOIMMUNE
MYASTHENIA GRAVIS
PATHOPHYSIOLOGY
Autoantibodies directed at the acetyl
choline receptor sites impair
transmission of impulses across the
myoneural junction. Therefore fewer
receptors are available for stimulation,
resulting in voluntary muscle weakness
that escalates with continued activity.
ASSESSMENT FINDINGS
INTERVENTIONS
MEDICAL AND NURSING
MANAGEMENT
MEDICATIONS
Cholinergic/
anticholinesterase::
neostiogmine, pyridostigmine,
endrophonium chloride
- adm. Meds on time
- give 30 mins before meals
with milk & crackers
- note for over- & underdosage
SE: sweating, salivation,
nausea, salivation, abdominal
cramps, bradycardia &
hypotension
glucocorticoids
antacids
ISTIONKO/USTCON/05
MULTIPLE SCLEROSIS
ISTIONKO/USTCON/05
diplopia
scotoma
blindness
muscle spasm
weakness
numbness
fatigue
increase susceptibility to infection
emotional instability
euphoria during remissions
Charcots triad : scanning speech,
intention tremors, nystagmus
lhermittes sign: sudden electric
shock sensation experienced on
passive flexion of the neck
dysphagia
ataxic gait
LP- increased levels of IgG & IgM
muscle weakness
diminished reflexes of the
lower extremities
quadriplegia
neuromuscular respiratory
failure
paresthesias of the hand and
feet
pain related to the
demyelination of the sensory
fibers
blindness
bulbar muscle weakness
inability to swallow or clear
secretions
instability of the cardiovascular
DEGENERATIVE DISORDERS
PARKINSONS DISEASE
system
CSF increased CHON
Laboratory Test
PET scanning in evaluating
levels of levodopa uptake and
conversion
Laboratory and imaging studies are not
helpful in the diagnosis of parkinsons
ISTIONKO/USTCON/05
Medical Management
- Treatment is directed in controlling
symptoms and maintaining
functional independence because
there are no medical or surgical
that prevents disease progression.
- Care is individualized for each
patient
- Pharmacologic management is the
mainstay of treatment
- Patients are usually cared at home
and admitted to hospital when
complication arises
Surgical Management
Thalamotomy and
pallidotomyive in treating the
symptoms of parkinsons
disease
Neural transplantation of
adrenal medullary tissue is
performed in effort to restore
normal dopamine release
Deep brain stimulation
pacemaker like brain implants
It is not always practiced but it
is done if the condition is
serious
It does not produce permanent
improvement
Nursing Management
Improve mobility through daily
exercise
Enhance self care activities
Pharmacologic Management
Drugs act by:
Increasing striatal
dopaminergic activity
Reducing excessive excitatory
cholinergic neurons on the
extrapyramidal tract
Acting on neurotransmitter
pathway other than the
dopaminergic pathway.
Antiparkinsonian medications
Levodopa is the most effective
agent and mainstay of
treatment
Levodopa is converted to
dopamine in the basal ganglia
promoting relief
Prolong use could lead to
dyskinesia (abnormal
involuntary movements)
Patient may also experience
on-off syndrome
Anticholinergic therapy
Effective in controlling tremor
and rigidity
May be combined with
levodopa
Counteract neurotransmitter
acetylcholine
IOP must be monitored
Poorly tolerated by elderly
Patients with hyperplasia are
monitored for signs of urinary
retention.
Antiviral therapy
ISTIONKO/USTCON/05
Amantadine hydrochloride
(Symmetrel); effective agent
against parkinsons
Reduces tremor, rigidity and
bradykinesia
Has antiglutamatergic
properties
Dopamine agonist
Bromocryptine mesylate and
pergolide (ergot derivatives)
are dopamine receptor agonist
Useful in postponing the
initiation of carbidopa or
levodopa therapy
MAO inhibitors
Eldepryl inhibits dopamine
breakdown and slows the
progression of the disease
COMT inhibitors
Entacapone (Comtess) and
tolcapone (Tasmar) have little
effect on parkinsonian
symptoms when given alone
but increases the duration of
action when given with
carbidopa or levidopa
Blocks the enzyme that
metabolizes levodopa
Antidepressants
Trycyclic antidepressants
alleviates depression that is
common in parkinsons disease
Amitriptyline is prescribed
because of its anticholinergic
and antidepressant effect
SSRI are effective in treating
depression but may aggravate
parkinsonism
Antihistamine
HUNTINGTONS DISEASE
Involves premature death of cells in the
striatum of the basal ganglia involved in
the control of movement. There is also
loss of cells in the cortex, region of the
brain associated with thinking, memory,
perception and judgement, and in the
cerebellum the area that coordinates
voluntary muscle activity. Glutamine a
protein that collects inside the cells is the
one that causes cell death. The cells
destruction results in a lack of
neurotransmitter GABA and
acetylcholine which inhibit nerve action.
The disease progresses slowly and
usually strikes persons aging from 35 to
35 yrs of age
ISTIONKO/USTCON/05
Clinical manifestation
chorea
intellectual decline
emotional disturbance
constant writhing and twisting
facial movements produces tics
and grimaces
speech is affected
chewing and swallowing are
difficult
choreiform movement persist but
diminish during sleep
gait becomes disorganized
cognitive function is altered
illness results in suicidal
depression, anxiety, euphoria
and psychosis
disjointed movements
hallucinations
dementia
Laboratory tests
CT scan
MRI
Recombinant DNA
Nursing management
Use padded heel and elbow
protectors
Keep the skin clean
Encourage ambulation to
improve muscle tone
Encourage patient to wear
paddings
Secure the patient in bed or
chair
Learn the position that is best
for the patient
Talk to the patient before
meals to promote relaxation
Do not interpret stiffness or
sudden turning away of head
as a means of saying no for
sometimes it is caused by
involuntary movement
Placed bite sized foods
Wait the patient in chewing and
swallowing his food
Use blenderized meals if
patient cant chew
Learn how the patient
expresses his emotion
Pharmacologic management
Thiothixene hydrochloride
(Navane) and haloperidol
decanoate (Haldol), blocks
dopamine receptors which
improves chorea in patients
Chorea is also lessened with
tetrabenazine
Patients having parkinsons
symptoms like are given with
antiparkinson medication such
as levodopa
Patients having emotional
disturbances may be given
with antidepressants
Psychotic symptoms are
usually suppressed by giving
antipsychotics
Speech therapy
Do not abandon the patient because the
disease is usually terminal, patients are
living until the end
AMYOTROPHIC LATERAL
SCLEROSIS (Lou Gehrigs disease)
ISTIONKO/USTCON/05
Clinical Manifestations
fatigue
progressive muscle weakness
cramps
fasciculation
incoordination
atrophy of the muscles in arms,
trunks and legs
spasticity
deep tendon stretch reflexes
become brisk and overactive
Pharmacologic management
Riluzole (Rilutek) a glutamate
antagonist that slows the
deterioration of motor neurons
Baclofen (lioresal), dantrolene
sodium (Dantrium) or
diazepam (Valium) may be
useful for patients with
spasticity
ISTIONKO/USTCON/05
Clinical manifestations
1. forgetfulness
and
subtle
memory loss
2. depression
3. loses the ability to recognize
familiar faces, places and
objects
4. they may repeat similar stories
because they forget that they
have already told them
5. conversation becomes difficult
6. the ability to formulate
concepts disappears
7. changes in personality
8. becomes anxious, combative,
suspicious and paranoid
9. patient may wander at night
10. has
dysphagia
and
incontinence
Laboratory test
contractures
The patient and family are
encourage to join in decision
making including end to life
decisions
The knowledge of the family
regarding handling the
condition are assessed and
modifications are done by the
nurse
The nurse may need to help
boost the confidence of an
adolescent and older adult
patient by encouraging them to
pursue job training to become
economically independent
Guidance in accessing adult health care
and finding appropriate programs in sex
education
Nursing management
Provide
a
predictable
environment that helps the
person
interpret
his
surroundings and activities
Use pleasant manner of
speaking
Use simple instructions
Use simple explanations
Always display clocks and
calendars
Colorcoding the doorway may
help the patient in recognizing
his room
Removed
all
hazardous
objects
Patients intake of food and
medications are monitored
Pharmacologic management
Tacrine hydrochloride (Cognex)
an agent that enhances
acetylcholine uptake in the
brain,
thus
maintaining
memory skills for a period of
time
Donepezil
(Aricept)
acetylcholinesterase inhibitor
Rivastigmine (Exelon
MUSCULAR DYSTROPHIES
ISTIONKO/USTCON/05
Nursing Intervention
The goals of the patient & the nurse
are to maintain function at optional
levels & to enhance the quality of life.
Therefore, the patients physical
requirements which are considerable,
are addressed w/o loosing sight of
emotional & developmental needs.
The patient & the family are actively
involved in decision making including
end of life decision.
During hospitalization per treatment of
complications, the knowledge &
expertise of the patient and family
members responsible for care giving in
the home are assessed. Because the
patient & family caregivers often have
develop care giving strategies need to be
acknowledged & accepted, & provisions
must be made to ensure that they are
maintained during hospitalization.
Muscle Contracture
Disuse Atrophy
Spinal Deformity
- Weakness of trunk muscles
- Spinal Collapse
Compromised Pulmonary Function
- Maybe due either to
progression of the disease or to
deformity of thorax secondary to
severe scoliosis
Dental & Speech Problem
- May result from weakness of
facial muscles, which make it
difficult to attend to dental
hygiene & to speak coherently.
GI Problems
- Gastric dilation
- Rectal Prolapse
- Fecal Impaction
ISTIONKO/USTCON/05
Cardiomyopathy
The pathologic features include:
Degeneration & loss of muscle
fibers
Variation in muscle fiber size
Phagocytosis
Regeneration & Replacement of
muscle tissue
Nursing Intervention
The goals of the patient & the nurse
are to maintain function at optional
levels & to enhance the quality of life.
Therefore, the patients physical
requirements which are considerable,
are addressed w/o loosing sight of
emotional & developmental needs.
The patient & the family are actively
involved in decision making including
end of life decision.
During hospitalization per treatment of
complications, the knowledge &
expertise of the patient and family
members responsible for care giving in
the home are assessed. Because the
patient & family caregivers often have
develop care giving strategies need to be
acknowledged & accepted, & provisions
must be made to ensure that they are
maintained during hospitalization.
HERNIATION OF CEREBRAL
INTERVERTEBRAL DISK
ISTIONKO/USTCON/05
- Spinal Collapse
Compromised Pulmonary Function
- Maybe due either to
progression of the disease or to
deformity of thorax secondary to
severe scoliosis
Dental & Speech Problem
- May result from weakness of
facial muscles, which make it
difficult to attend to dental
hygiene & to speak coherently.
GI Problems
- Gastric dilation
- Rectal Prolapse
- Fecal Impaction
Cardiovascular Problem:
Cardiomyopathy
The pathologic features include:
Degeneration & loss of muscle
fibers
Variation in muscle fiber size
Phagocytosis
Regeneration & Replacement of
muscle tissue
Medical Management
Herniation of the cervical and
the lumbar disks occur most
commonly and are usually
managed conservatively with
bed rest.
Surgical Management
Discectomy
- Removal of herniated
- Fracture
- Tumor
- Infection
Cauda Equina Syndrome
FINDINGS:
MRI
TRAUMATIC
SPINAL CORD INJURY
fragments
Laminetomy
- Removal of the bone between
the spinal process.
Hemilaminectomy
- Removal of part of the lamina
Discectomy with Fusion
- A bone graft is used to fused
the vertebral spinous process.
Foraminotomy
- Removal of the Intervertebral
foramen.
WHIPLASH INJURY
ISTIONKO/USTCON/05
STIONKO/USTCON/05
Impairment of muscle
function.
consecutive Schwann cells lose their
myelin, conduction slows to a halt. A
whole nerve may contain several
thousand nerve fibers. Therefore,
impulse conduction along individual
fibers may be unaffected, may be mildly
slowed, or blocked. The longer the
nerve segment, the greater chance of
detecting mild degrees of slowing
MONONEUROPATHY
Symptoms
Impairment of sensation in a body
part supplied by a specific
nerve
o Numbness, decreased
sensation
o Tingling, burning, pain,
abnormal sensations
o Loss of sensation
Impairment of movement in one
muscle supplied by a specific
nerve
o Weakness
o Paralysis (total loss of
movement)
Note: Symptoms are isolated to one
location.
Signs and tests
Neuromuscular examination of the
affected area may indicate which nerve
is involved. Reflexes may be abnormal in
the area. Symptoms are isolated to one
nerve area.
Tests for mononeuropathy may include
the following:
EMG (a recording of electrical
activity in muscles)
Nerve conduction tests
Nerve biopsy
ISTIONKO/USTCON/05